Skip to main content
Premium Trial:

Request an Annual Quote

Elsevier, Maverix Ink Software Integration Agreement

NEW YORK (GenomeWeb) – Maverix Biomics and Elsevier have signed an agreement that lets the companies integrate the Maverix Analytic platform with Elsevier's Pathway Studio software to improve the analysis and interpretation of next-generation sequencing data.

The companies made the announcement at the 23rd International Molecular Medicine Tri-Conference being held this week in San Francisco, Calif.

Customers of the integrated offering will have access to published information from Elsevier journals as well as tools for aligning raw sequences, for variant and expression analysis, and for analyzing and visualizing disease mechanisms. Access to both solutions will enable customers to save time, reduce workloads, and improve the accuracy of their results, Jaqui Hodgkinson, vice president, product development of Elsevier Life Sciences Solutions, said in statement.

Financial and other terms of the agreement were not disclosed.


The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.